|
|
|
| Join The Advancing RNA Community | Introducing Advancing RNA, an online community designed to be a forum and resource for professionals working on RNA-based therapeutics to better understand the challenges that confront them in areas like analytical/quality, manufacturing, formulation, outsourcing, clinical research, and supply chain/logistics. Sign up for the Advancing RNA newsletter, delivered to your inbox weekly. |
|
|
|
|
Life Science Leader wishes you a happy New Year and announces plans for 2024. |
|
|
|
|
Former president of Cardinal Health’s nuclear and precision health solutions group Tiffany Olson discusses her work on Bayer's Xofigo and how she anticipated the rise of radiopharmaceuticals. |
|
|
|
Founded in late 2019, KeifeRx is repurposing oncology drugs for neurodegenerative disorders. KeifeRx has a full range of neuroscience (NS) drug candidates in development, spanning later-stage clinical assets to several novel pre-IND technologies. |
|
|
|
A new series from Life Science Leader looks backward, and forward, at the biopharmaceutical companies that have previously appeared in the pages of Life Science Leader magazine. |
|
|
|
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
| Connect With Life Science Leader: |
|
|
|
